-
Study aim
-
We hypothesized that moderate aerobic training lowers the serum level of S100B and MDA or increases the serum level of SOD and improves headache indices and general health status in wMIG.
-
Design
-
The study is a randomized controlled clinical trial (RCT) with a semi-experimental design (three groups with pre- and post-testing).
-
Settings and conduct
-
Imam reza Hospital, Kermanshah
-
Participants/Inclusion and exclusion criteria
-
The inclusion criteria were as follows: (1) no history of regular exercise in the previous 6 months; (2) no chronic diseases such as cardiovascular, hypertension, diabetes, arthritis, cancer, asthma, AIDS, meningitis or MS; (3) confirming headache by the neurologist; (4) Having an age range of 18 to 45 years. Exclusion criteria comprised: (1) situations that researchers understood during the research period, such as pregnancy, breastfeeding and abuse of drugs or alcohol; (2) participation in any additional exercise training programmes; (3) no interest on the part of the volunteer in continuing or making a change in their personal life schedule; (4) contracting COVID-19, and 5) voluntary finished the protocol.
-
Intervention groups
-
1) exercise+migraineurs group (doing 8 weeks of endurance exercise training, running and taking medicine prescribed by the doctor).
2) non-exercise+migraineurs group (only taking medicine prescribed by the doctor).
3. A healthy control group (without medicine and healthy).
-
Main outcome variables
-
matrix metalloproteinases-2 (MMP-2), matrix metalloproteinases-9 (MMP-9), Inhibitors of matrix metalloproteinases-1(TIMP-1),Inhibitors of matrix metalloproteinases-2 (TIMP-2), S100 calcium-binding protein B(S100B)